These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 14720450)

  • 21. Steatosis and insulin resistance in response to treatment of chronic hepatitis C.
    Negro F
    J Viral Hepat; 2012 Jan; 19 Suppl 1():42-7. PubMed ID: 22233413
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of the prevalence and grade of steatosis in patients with chronic hepatitis C with the host and viral factors.
    Liakina V; Speiciené D; Irnius A; Semuchiniené T; Valantinas J
    Acta Gastroenterol Belg; 2007; 70(3):260-6. PubMed ID: 18074734
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic steatosis in hepatitis C virus genotype 3 infection: does it correlate with body mass index, fibrosis, and HCV risk factors?
    Sharma P; Balan V; Hernandez J; Rosati M; Williams J; Rodriguez-Luna H; Schwartz J; Harrison E; Anderson M; Byrne T; Vargas HE; Douglas DD; Rakela J
    Dig Dis Sci; 2004 Jan; 49(1):25-9. PubMed ID: 14992430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
    Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus, and alcohol.
    Monto A; Alonzo J; Watson JJ; Grunfeld C; Wright TL
    Hepatology; 2002 Sep; 36(3):729-36. PubMed ID: 12198667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms and significance of liver steatosis in hepatitis C virus infection.
    Negro F
    World J Gastroenterol; 2006 Nov; 12(42):6756-65. PubMed ID: 17106922
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity and non-alcoholic fatty liver disease in chronic hepatitis C.
    Younossi ZM; McCullough AJ; Ong JP; Barnes DS; Post A; Tavill A; Bringman D; Martin LM; Assmann J; Gramlich T; Mullen KD; O'Shea R; Carey WD; Ferguson R
    J Clin Gastroenterol; 2004 Sep; 38(8):705-9. PubMed ID: 15319656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection.
    Price JC; Ma Y; Scherzer R; Korn N; Tillinghast K; Peters MG; Noworolski SM; Tien PC
    Hepatology; 2017 Mar; 65(3):853-863. PubMed ID: 27981599
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype-specific mechanisms for hepatic steatosis in chronic hepatitis C infection.
    Hui JM; Kench J; Farrell GC; Lin R; Samarasinghe D; Liddle C; Byth K; George J
    J Gastroenterol Hepatol; 2002 Aug; 17(8):873-81. PubMed ID: 12164963
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis.
    Castéra L; Hézode C; Roudot-Thoraval F; Lonjon I; Zafrani ES; Pawlotsky JM; Dhumeaux D
    Gut; 2004 Mar; 53(3):420-4. PubMed ID: 14960527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of insulin resistance, viral load, and adipokine levels with liver histology in patients with chronic hepatitis C: an observational, multicenter study in Turkey.
    Aksu HS; Kurtaran B; Onlen Y; Namiduru M; Inkaya AC; Kandemir O; Doran F; Evirgen O; Alpay Y; Tekin SK; Kurekci Y; Unlu B; Midikli D; Taşova Y; Ozdener F; Erdogan S
    Eur J Gastroenterol Hepatol; 2012 Dec; 24(12):1393-9. PubMed ID: 23114743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.
    Matos CA; Perez RM; Pacheco MS; Figueiredo-Mendes CG; Lopes-Neto E; Oliveira EB; Lanzoni VP; Silva AE; Ferraz ML
    J Gastroenterol Hepatol; 2006 Aug; 21(8):1236-9. PubMed ID: 16872303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C.
    Giannini E; Ceppa P; Botta F; Mastracci L; Romagnoli P; Comino I; Pasini A; Risso D; Lantieri PB; Icardi G; Barreca T; Testa R
    Am J Gastroenterol; 2000 Nov; 95(11):3211-7. PubMed ID: 11095344
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic steatosis in hepatitis C: comparison of diabetic and nondiabetic patients in the hepatitis C antiviral long-term treatment against cirrhosis trial.
    Lok AS; Everhart JE; Chung RT; Padmanabhan L; Greenson JK; Shiffman ML; Everson GT; Lindsay KL; Bonkovsky HL; Di Bisceglie AM; Lee WM; Morgan TR; Ghany MG; Morishima C;
    Clin Gastroenterol Hepatol; 2007 Feb; 5(2):245-54. PubMed ID: 17296533
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Liver steatosis associated with chronic hepatitis C.
    Irimia E; Mogoantă L; Predescu IO; Efrem IC; Stănescu C; Streba LA; Georgescu AM
    Rom J Morphol Embryol; 2014; 55(2):351-6. PubMed ID: 24969985
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis.
    Adinolfi LE; Restivo L; Zampino R; Guerrera B; Lonardo A; Ruggiero L; Riello F; Loria P; Florio A
    Atherosclerosis; 2012 Apr; 221(2):496-502. PubMed ID: 22385985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Complement Component 3 as a Surrogate Hallmark for Metabolic Abnormalities in Patients with Chronic Hepatitis C.
    Himoto T; Hirakawa E; Fujita K; Sakamoto T; Nomura T; Morishita A; Yoneyama H; Haba R; Masaki T
    Ann Clin Lab Sci; 2019 Jan; 49(1):79-88. PubMed ID: 30814081
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance: a major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C.
    El Ray A; Asselah T; Moucari R; El Ghannam M; Taha AA; Saber MA; Akl M; Atta R; Shemis M; Radwan AS; Ghali A; Paradis V; Marcellin P
    Eur J Gastroenterol Hepatol; 2013 Apr; 25(4):421-7. PubMed ID: 23470266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Steatosis in hepatitis C virus infection. Response to anti-viral therapy.
    Szanto P; Grigorescu M; Dumitru I; Serban A
    J Gastrointestin Liver Dis; 2006 Jun; 15(2):117-24. PubMed ID: 16802005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucose intolerance and hypoadiponectinemia are already present in lean patients with chronic hepatitis C infected with genotype non-3 viruses.
    Anty R; Gelsi E; Giudicelli J; Mariné-Barjoan E; Gual P; Benzaken S; Saint-Paul MC; Sadoul JL; Huet PM; Tran A
    Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):671-7. PubMed ID: 17625437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.